Choong Ang Vaccine Laboratory Co., Ltd.

A072020

KR7072020001

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
10,870 ^KRW	+0.74%		+2.26%	-1.27%

2023	Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2023	Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Tranche Update on Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan announced on October 13, 2022.

January 05, 2023 at 12:50 am EST

From October 13, 2022 to December 31, 2022, the company has repurchased 94,928 shares, representing 0.98% for KRW 1,069.14 million. With this, the company has completed the repurchase of 94,928 shares, representing 0.98% for KRW 1,069.14 million under the buyback announced on October 13, 2022.

Latest news about Choong Ang Vaccine Laboratory Co., Ltd.

Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-20	CI
Tranche Update on Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan announced on October 13, 2022.	23-01-05	CI
Tranche Update on Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan announced on October 13, 2022.	23-01-05	CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback announced on October 13, 2022, has closed with 100,000 shares, representing 1.03% for KRW 1,121.97 million.	23-01-02	CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-27	CI
Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.	22-10-12	CI
Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan.	22-10-12	CI
Choong Ang Vaccine Laboratory Co., Ltd.(KOSDAQ:A072020) dropped from S&P Global BMI Index	22-09-19	CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback announced on October 8, 2021, has expired.	22-01-06	CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-26	CI
Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.	21-10-08	CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan Shortened to January 7, 2022.	21-10-07	CI
Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan.	21-10-07	CI
Tranche Update on Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan announced on March 13, 2020.	20-03-19	CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback announced on March 13, 2020 has closed with 100,000 shares, representing 1% for KRW 1,385.28 million.	20-03-17	CI
Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.	20-03-13	CI
Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan.	20-03-12	CI
Choong Ang Vaccine Laboratory Co., Ltd.(KOSDAQ:A072020) added to S&P Global BMI Index	18-09-24	CI
Choong Ang Vaccine Laboratory Co., Ltd.(KOSDAQ:A072020) dropped from S&P Global BMI Index	17-09-18	CI
Choong Ang Vaccine Laboratory Co., Ltd.(KOSDAQ:A072020) added to S&P Global BMI Index	16-09-19	CI
Korea Securities Finance Corporation, Investment Arm acquired 5.09% stake in Choong Ang Vaccine Laboratory.	14-04-11	CI

Chart Choong Ang Vaccine Laboratory Co., Ltd.

Duration

Period

Chart Choong Ang Vaccine Laboratory Co., Ltd.

More charts

Company Profile

Choong Ang Vaccine Laboratory Co., Ltd. is a Korea-based company mainly engaged in the manufacturing and marketing of veterinary vaccines. The Company provides veterinary vaccines for fowl, dogs, pigs, cattle, rabbits, cats, fishes and others under the brand name SuiShot, PoulShot, Canishot, BoviShot, FeliShot, RabbiShot and AquaShot. The Company also provides diagnosis services, and distributes other veterinary drugs, such as antibiotics, anthelmintics, disinfectants and feed additives. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Veterinary Drugs

	1st Jan change	Capi.
CHOONG ANG VACCINE LABORATORY CO., LTD.	-1.27%	75.86M
ZOETIS INC.	-19.76%	72.76B
ELANCO ANIMAL HEALTH INCORPORATED	-11.88%	6.49B
VIRBAC	-3.48%	3.11B
VIMIAN GROUP AB	+2.36%	1.44B
JINYU BIO-TECHNOLOGY CO., LTD.	-15.13%	1.37B
VETOQUINOL SA	-7.91%	1.19B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-25.63%	1.24B
WUHAN KEQIAN BIOLOGY CO.,LTD	-10.84%	1.17B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-.--%	1.05B